Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR.
Siebolts U, Varnholt H, Drebber U, Dienes HP, Wickenhauser C, Odenthal M
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effect of method of preservation, tissue type and storage of FFPE blocks on expression of miR-16a in liver, breast, intestine, colon, lymph node, and bone marrow specimens.
Summary of Findings
Expression of miR-16a was similar in unstored matched snap-frozen and FFPE colon and liver specimens. Absolute levels of miR-16 amplified from FFPE specimens varied slightly between tissue types (~5 fold variation) and between specimens from the same tissue type, which the authors note could be due to disease state. Generally, the highest levels of miR-16a were found in liver and intestine while the lowest were found in bone marrow, but even in bone marrow specimens, there was significant amplification of miR-16a. miR-16a levels in FFPE lymph node specimens that were stored for 17 or 27 years were approximately 40-50% of levels in recently obtained specimens (p<0.01). A non-significant reduction in miR-16a was found in blocks stored for 7 y compared to unstored blocks.
Biospecimens
TissueLiverTissueColorectalTissueSmall BowelTissueBone MarrowTissueLymph NodeTissueBreastPreservation Types
FormalinFrozenDiagnoses
CirrhosisCrohn's DiseaseHepatitisNeoplasticCarcinomaNeoplasticBenignUlcerative ColitisPlatforms
RNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location Bone marrowBreastColonIntestineLiverLymph nodeBiospecimen Preservation Type of fixation/preservation Formalin (buffered)Snap frozenStorage Storage duration 0 years17 years27 years7 yearsReal-time qRT-PCR Specific Targeted nucleic acid miR-16a